supp.fit

Coenzyme Q10: study protocols

242 study groups say how much Coenzyme Q10 participants took a day. These are the doses the studies gave. They are not a recommendation.

Coenzyme Q10: what the research found →

Dose per serving from products

4,865 products in our catalogue print how much Coenzyme Q10 a serving holds.

Most common: 50 mg to 100 mg, 35% of 4,865 products.

Dose per servingProducts
2.5 mg or less
158
2.5 mg to 5 mg
158
5 mg to 10 mg
294
10 mg to 25 mg
362
25 mg to 50 mg
808
50 mg to 100 mg
1,686
100 mg to 250 mg
951
250 mg to 500 mg
359
over 500 mg
89

Dose per serving from research

239 study groups in 185 studies say how much Coenzyme Q10 participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 100 mg to 250 mg, 39% of 239 study groups.

Daily doseStudy groups
25 mg or less
10
25 mg to 50 mg
17
50 mg to 100 mg
62
100 mg to 250 mg
94
250 mg to 500 mg
40
500 mg to 1 g
10
over 1 g
6

Commonly used together

69 of 242 study groups took Coenzyme Q10 with something else. Shown: what 3 or more different studies gave. The 10 most common of 14.

What was given together, not what works together.

Taken withStudy groups
Selenium
21
Vitamin E
15
Niacin
10
Omega-3 Fatty Acids
9
Folic Acid
8
Red Yeast Rice
8
Riboflavin
8
Vitamin C
8
Berberine
5
Policosanol
4

242 study groups

Study
Coenzyme Q10 supplementation during pregnancy reduces the risk of pre-eclampsia
2009 · CoQ10 group · Women at increased risk of pre-eclampsia during pregnancy
200 mg—118
Effect of coenzyme Q10 on risk of atherosclerosis in patients with recent myocardial infarction
2003 · CoQ group (group A) · Patients after acute myocardial infarction; age and sex not reported
120 mg1 year73
Randomized, double-blind placebo-controlled trial of coenzyme Q10 in patients with acute myocardial infarction
1998 · intervention group A · Patients with acute myocardial infarction; age and sex not specified
120 mg4 weeks73
Protection by coenzyme Q10 from myocardial reperfusion injury during coronary artery bypass grafting
1994 · group 1 · Patients undergoing elective coronary artery bypass grafting
150 mg7 days—
Reduced Cardiovascular Mortality 10 Years after Supplementation with Selenium and Coenzyme Q10 for Four Years: Follow-Up Results of a Prospective Randomized Double-Blind Placebo-Controlled Trial in Elderly Citizens
2015 · Active treatment · Elderly Swedish community-dwelling adults; mean age 78 years; men and women; described as healthy, with low baseline selenium status
200 mg4 years221
Still reduced cardiovascular mortality 12 years after supplementation with selenium and coenzyme Q10 for four years: A validation of previous 10-year follow-up results of a prospective randomized double-blind placebo-controlled trial in elderly
2018 · Active treatment group · Elderly healthy Swedish community-dwelling adults; mean age 78 years, men and women
200 mg1461 days221
Supplementation with Selenium and Coenzyme Q10 Reduces Cardiovascular Mortality in Elderly with Low Selenium Status. A Secondary Analysis of a Randomised Clinical Trial
2016 · active treatment group · Adults aged 70–80 years in Sweden, without a stated requirement for a diagnosed condition; participants were analysed in strata by baseline serum selenium concentration.
200 mg4 years219
The clinical outcome of Montelukast versus co-enzyme Q10 in adult patients with sepsis: A randomized controlled clinical trial
2026 · CoQ10 · Adults with sepsis
210 mg—30
Safety assessment of coenzyme Q10 (Kaneka Q10) in healthy subjects: a double-blind, randomized, placebo-controlled trial
2006 · 300 mg dose · healthy adult volunteers
300 mg4 weeks—
The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: a randomized double-blind trial
2014 · CoQ10 group · Adults with moderate to severe chronic heart failure
300 mg2 years—
Discovering the Potential Value of Coenzyme Q10 as an Adjuvant Treatment in Patients With Depression
2024 · CoQ10 group · Patients with moderate or severe depression; age and sex not reported
200 mg8 weeks36
Coenzyme q10 liquid supplementation in dyslipidemic subjects with statin-related clinical symptoms: a double-blind, randomized, placebo-controlled study
2019 · CoQ10 group · Adults aged 18 years or older, either sex, with dyslipidemia inadequately controlled on statins and statin intolerance
100 mg90 days30
The effects of coenzyme Q10 supplementation on metabolic profiles and parameters of mental health in women with polycystic ovary syndrome
2022 · CoQ10 group · Women aged 18–40 with polycystic ovary syndrome
100 mg12 weeks28
Coenzyme Q10 supplementation decreases statin-related mild-to-moderate muscle symptoms: a randomized clinical study
2014 · Q10 group · Adults aged 40–65 of both sexes with mild-to-moderate statin-related muscle pain
100 mg30 days25
Oral coenzyme Q10 supplementation in patients with nonalcoholic fatty liver disease: effects on serum vaspin, chemerin, pentraxin 3, insulin resistance and oxidative stress
2014 · coQ10 group · Adults with nonalcoholic fatty liver disease
100 mg4 weeks22
Water-soluble coenzyme Q10 formulation (Q-TER(®)) in the treatment of presbycusis
2010 · Group A · Patients with presbycusis; age and sex not reported
160 mg30 days20
Noninvasive instrumental evaluation of coenzyme Q(10) phytosome on endothelial reactivity in healthy nonsmoking young volunteers: A double-blind, randomized, placebo-controlled crossover clinical trial
2022 · CoQ10 phytosome · Healthy nonsmoking volunteers aged 18–40 years
150 mg4 weeks20
Hemodynamic effects of fenofibrate and coenzyme Q10 in type 2 diabetic subjects with left ventricular diastolic dysfunction
2008 · fenofibrate + CoQ · Adults aged 40–79 years with type 2 diabetes and left ventricular diastolic dysfunction
200 mg26 weeks19
Impact of coenzyme Q-10 on parameters of cardiorespiratory fitness and muscle performance in older athletes taking statins
2012 · CoQ10 treatment · Athletes aged 50 years or older taking stable doses of statins
200 mg6 weeks19
Effects of Coenzyme Q10 Supplementation on Physical Function Adaptations to High-Intensity Interval Training in Older Adults
2025 · HIIT + CoQ10 · Healthy, sedentary adults aged 65–75 years; 22 men and 16 women enrolled across the study
100 mg8 weeks19
Effect of coenzyme q10 on myopathic symptoms in patients treated with statins
2007 · coenzyme Q10 · Patients with statin-associated myopathic symptoms
100 mg30 days18
Hemodynamic effects of fenofibrate and coenzyme Q10 in type 2 diabetic subjects with left ventricular diastolic dysfunction
2008 · CoQ · Adults aged 40–79 years with type 2 diabetes and left ventricular diastolic dysfunction
200 mg26 weeks16
The monitoring role of otoacoustic emissions and oxidative stress markers in the protective effects of antioxidant administration in noise-exposed subjects: a pilot study
2009 · Q-Ter group · Normal volunteers exposed to noise, at risk of sound-induced cochlear damage
200 mg7 days10
Combined effect of coenzyme Q10 and fenofibrate on forearm microcirculatory function in type 2 diabetes
2003 · CoQ · Adults with dyslipidaemic type 2 diabetes
200 mg12 weeks—
Combined effect of coenzyme Q10 and fenofibrate on forearm microcirculatory function in type 2 diabetes
2003 · Fenofibrate plus CoQ · Adults with dyslipidaemic type 2 diabetes
200 mg12 weeks—
Antifatigue effects of coenzyme Q10 during physical fatigue
2008 · 100 mg/d coenzyme Q10 group · healthy volunteers
100 mg8 days—
Coenzyme Q10 treatment in infertile men with idiopathic asthenozoospermia: a placebo-controlled, double-blind randomized trial
2009 · coenzyme Q(10) · Men aged 27–39 with idiopathic asthenozoospermia
200 mg26 weeks—
Coenzyme Q10 improves endothelial dysfunction in statin-treated type 2 diabetic patients
2009 · oral CoQ10 · Adults aged 40–79 with type 2 diabetes, on stable-dose statin therapy, and endothelial dysfunction
200 mg12 weeks—
Coenzyme Q10 improves seminal oxidative defense but does not affect on semen parameters in idiopathic oligoasthenoteratozoospermia: a randomized double-blind, placebo controlled trial
2011 · CoQ10 group · Infertile men with idiopathic oligoasthenoteratozoospermia
200 mg12 weeks—
Coenzyme Q10 benefits symptoms in Gulf War veterans: results of a randomized double-blind study
2014 · Q100 · Gulf War veterans with Gulf War illness; ages and sex distribution not specified
100 mg15 weeks—
Effect of Coenzyme Q10 on Oxidative Stress, Glycemic Control and Inflammation in Diabetic Neuropathy: A Double Blind Randomized Clinical Trial
2014 · CoQ10 · Patients with type 2 diabetes and neuropathic signs
200 mg12 weeks—
The effect of dietary intake of coenzyme Q10 on skin parameters and condition: Results of a randomised, placebo-controlled, double-blind study
2017 · 150 mg CoQ10 · Healthy subjects; age and sex not reported
150 mg12 weeks—
Evaluating the Effect of Coenzyme Q10 Augmentation on Treatment of Bipolar Depression: A Double-Blind Controlled Clinical Trial
2018 · adjuvant CoQ10 group · Patients with bipolar disorder experiencing a current depressive episode
200 mg8 weeks—
Impact of Coenzyme Q10 and Selenium on Seminal Fluid Parameters and Antioxidant Status in Men with Idiopathic Infertility
2021 · CoQ10 · Men with idiopathic oligoasthenoteratospermia
200 mg90 days—
Effect of coenzyme Q10 on post-extraction tissue healing in wisdom tooth Surgery: double-blind randomized clinical trial
2025 · CoQ10 group · People undergoing wisdom tooth extraction; age and sex not stated
100 mg30 days—
Effect of coenzyme Q10 therapy in patients with congestive heart failure: a long-term multicenter randomized study
1993 · coenzyme Q10 · Adults aged 26–89 years with chronic congestive heart failure, NYHA functional class III or IV, receiving conventional heart-failure treatment
2 mg/kg1 year319
Improved cardiovascular health by supplementation with selenium and coenzyme Q10: applying structural equation modelling (SEM) to clinical outcomes and biomarkers to explore underlying mechanisms in a prospective randomized double-blind placebo-controlled intervention project in Sweden
2022 · Active treatment group · Adults aged 70–88 years with low selenium status and age-related low coenzyme Q10 levels
200 mg4 years221
Coenzyme Q10 combined with trimetazidine in the prevention of contrast-induced nephropathy in patients with coronary heart disease complicated with renal dysfunction undergoing elective cardiac catheterization: a randomized control study and in vivo study
2018 · CoQ10 plus TMZ group · Adults aged 18 years or older, male or female, with coronary heart disease and renal insufficiency undergoing elective cardiac catheterization
60 mg6 days75
Safety assessment of coenzyme Q10 (Kaneka Q10) in healthy subjects: a double-blind, randomized, placebo-controlled trial
2006 · 600 mg dose · healthy adult volunteers
600 mg4 weeks—
Safety assessment of coenzyme Q10 (Kaneka Q10) in healthy subjects: a double-blind, randomized, placebo-controlled trial
2006 · 900 mg dose · healthy adult volunteers
900 mg4 weeks—
Improved Health-Related Quality of Life, and More Days out of Hospital with Supplementation with Selenium and Coenzyme Q10 Combined. Results from a Double Blind, Placebo-Controlled Prospective Study
2015 · active substance group · community-dwelling elderly adults; mean age 77 years; 51% male
200 mg1461 days221
Safety and efficacy of coenzyme Q10 supplementation in early chronic Peyronie's disease: a double-blind, placebo-controlled randomized study
2010 · CoQ(10) group · Patients with early chronic Peyronie's disease; age and sex not specified
300 mg24 weeks93
[L-carnitine combined with coenzyme Q10 for idiopathic oligoasthenozoospermia: A double-blind randomized controlled trial]
2018 · CoQ10 group · Men with idiopathic oligoasthenozoospermia
60 mg90 days63
Coenzyme Q10 as a potential add-on treatment for patients suffering from painful diabetic neuropathy: results of a placebo-controlled randomized trial
2022 · CoQ10 + pregabalin · Patients with painful diabetic neuropathy; age and sex not reported
300 mg8 weeks57
Coenzyme Q10 supplementation provides mild symptomatic benefit in patients with Parkinson's disease
2003 · CoQ(10) supplementation · Adults with treated and stable Parkinson's disease
360 mg4 weeks28
The effect of coenzyme Q10 on the exercise performance of cross-country skiers
1997 · Coenzyme Q10 supplementation · Finnish top-level cross-country skiers; age and sex not specified
90 mg—25
The effect of ubiquinone in diabetic polyneuropathy: a randomized double-blind placebo-controlled study
2012 · ubiquinone · Adults with type 2 diabetes and diabetic polyneuropathy; mean age 56 years
400 mg12 weeks24
Coenzyme Q10 and exercise training in chronic heart failure
2006 · oral CoQ(10) · Adults with stable NYHA class II or III chronic heart failure secondary to ischaemic heart disease; mean age 59 years; 20 men and 3 women
300 mg4 weeks23
Coenzyme Q10 and exercise training in chronic heart failure
2006 · CoQ(10) plus supervised exercise training (ET) · Adults with stable NYHA class II or III chronic heart failure secondary to ischaemic heart disease; mean age 59 years; 20 men and 3 women
300 mg4 weeks23
Oral coenzyme Q10 supplementation in patients with migraine: Effects on clinical features and inflammatory markers
2019 · CoQ10 · Non-menopausal women aged 18–50 with episodic migraine
400 mg90 days23
Acute effects of MitoQ on vascular endothelial function are influenced by cardiorespiratory fitness and baseline FMD in middle-aged and older adults
2024 · MitoQ · Middle-aged and older adults aged 45 years or older, including exercisers and non-exercisers
80 mg1 day23
Role for a water-soluble form of CoQ10 in female subjects affected by fibromyalgia. A preliminary study
2017 · CoQ10 administration · 22 female subjects with a diagnosis of fibromyalgia
400 mg—22
Efficacy of coenzyme Q10 in migraine prophylaxis: a randomized controlled trial
2005 · CoQ10 · Migraine patients
300 mg90 days21
Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline
2002 · coenzyme Q10 300 mg/d group · People with early Parkinson disease who did not require treatment for their disability; age and sex not reported
300 mg487 days—
Coenzyme Q10 in patients with end-stage heart failure awaiting cardiac transplantation: a randomized, placebo-controlled study
2004 · Ultrasome--CoQ10 · Patients with end-stage heart failure awaiting heart transplantation
60 mg90 days—
Effects of ubidecarenone in an exercise training program for patients with chronic obstructive pulmonary diseases
1991 · ubidecarenone-treated patients · Patients with chronic obstructive pulmonary disease participating in an exercise training program
50 mg——
Antifatigue effects of coenzyme Q10 during physical fatigue
2008 · 300 mg/d coenzyme Q10 group · healthy volunteers
300 mg8 days—
Can coenzyme q10 improve clinical and molecular parameters in fibromyalgia?
2013 · CoQ10 supplementation · Patients with fibromyalgia
300 mg40 days—
Coenzyme Q10 benefits symptoms in Gulf War veterans: results of a randomized double-blind study
2014 · Q300 · Gulf War veterans with Gulf War illness; ages and sex distribution not specified
300 mg15 weeks—
The effect of dietary intake of coenzyme Q10 on skin parameters and condition: Results of a randomised, placebo-controlled, double-blind study
2017 · 50 mg CoQ10 · Healthy subjects; age and sex not reported
50 mg12 weeks—
Effect of hydrosoluble coenzyme Q10 on blood pressures and insulin resistance in hypertensive patients with coronary artery disease
1999 · Coenzyme Q10 (group A) · Patients with essential hypertension and coronary artery disease receiving antihypertensive medication
120 mg8 weeks30
The Effects of Coenzyme Q10 Supplementation on Glucose Metabolism, Lipid Profiles, Inflammation, and Oxidative Stress in Patients With Diabetic Nephropathy: A Randomized, Double-Blind, Placebo-Controlled Trial
2018 · CoQ10 group · People with diabetic nephropathy; age and sex not specified
100 mg12 weeks25
Randomized, double-blind, placebo-controlled trial of coenzyme Q10 in isolated systolic hypertension
2001 · CoQ-treated group · Men and women with isolated systolic hypertension; ages not stated
120 mg12 weeks—
Coenzyme Q10 improves blood pressure and glycaemic control: a controlled trial in subjects with type 2 diabetes
2002 · CoQ alone · Adults with uncomplicated type 2 diabetes and dyslipidaemia
200 mg12 weeks—
Coenzyme Q10 improves blood pressure and glycaemic control: a controlled trial in subjects with type 2 diabetes
2002 · CoQ plus fenofibrate · Adults with uncomplicated type 2 diabetes and dyslipidaemia
200 mg12 weeks—
The effects of [omega]3 fatty acids and coenzyme Q10 on blood pressure and heart rate in chronic kidney disease: a randomized controlled trial
2009 · CoQ · Nondiabetic patients with stage 3–4 chronic kidney disease
200 mg8 weeks—
The effect of coenzyme Q10 supplementation on metabolic status of type 2 diabetic patients
2013 · Q10 group · Adults with type 2 diabetes; age and sex not specified
200 mg12 weeks—
Treatment of coenzyme Q10 for 24 weeks improves lipid and glycemic profile in dyslipidemic individuals
2018 · CoQ10 · Dyslipidemic subjects; age and sex not specified
120 mg24 weeks—
Pretreatment with coenzyme Q10 improves ovarian response and embryo quality in low-prognosis young women with decreased ovarian reserve: a randomized controlled trial
2018 · CoQ10 treatment (study group) · Women younger than 35 years with poor ovarian response and diminished ovarian reserve (AMH <1.2 ng/ml and AFC <5) undergoing ART
600 mg60 days76
Randomized crossover clinical trial of coenzyme Q10 and nicotinamide riboside in chronic kidney disease
2023 · CoQ10 · Adults aged 30–79 with chronic kidney disease (eGFR below 60 mL/min/1.73 m²) and 6-minute walking distance below 550 m
1.2 g6 weeks25
Mitochondria-targeted antioxidant supplementation improves 8 km time trial performance in middle-aged trained male cyclists
2021 · MitoQ supplementation · Healthy, recreationally trained male cyclists aged 44 ± 4 years
20 mg4 weeks19
MitoQ supplementation augments acute exercise-induced increases in muscle PGC1α mRNA and improves training-induced increases in peak power independent of mitochondrial content and function in untrained middle-aged men
2022 · MitoQ group · Healthy untrained middle-aged men, mean age 44 years; free of chronic illness and not selected for a diagnosed condition
20 mg31 days12
Royal jelly plus coenzyme Q10 supplementation improves high-intensity interval exercise performance via changes in plasmatic and salivary biomarkers of oxidative stress and muscle damage in swimmers: a randomized, double-blind, placebo-controlled pilot trial
2022 · RJQ group · Male high-level swimmers, approximately 19 years old, with at least Candidate Master of Sports or Master of Sports rank
60 mg10 days10
Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline
2002 · coenzyme Q10 600 mg/d group · People with early Parkinson disease who did not require treatment for their disability; age and sex not reported
600 mg487 days—
Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline
2002 · coenzyme Q10 1200 mg/d group · People with early Parkinson disease who did not require treatment for their disability; age and sex not reported
1.2 g487 days—
Coenzyme Q10 supplementation reduces corticosteroids dosage in patients with bronchial asthma
2005 · Antioxidants in addition to standard antiasthmatic therapy · Adults aged 25–50 with persistent mild to moderate bronchial asthma
120 mg16 weeks—
Beneficial effects of aged garlic extract and coenzyme Q10 on vascular elasticity and endothelial function: the FAITH randomized clinical trial
2013 · AGE/CoQ10 · Asymptomatic Los Angeles County firefighters with intermediate cardiovascular risk and high occupational stress
120 mg1 year—
Improvement of migraine symptoms with a proprietary supplement containing riboflavin, magnesium and Q10: a randomized, placebo-controlled, double-blind, multicenter trial
2015 · Verum (investigational nutritional product) · Adults aged 18–65 of either sex with migraine with or without aura, and at least 3 migraine attacks per month before recruitment
150 mg90 days63
Effect of Dietary Coenzyme Q10 Plus NADH Supplementation on Fatigue Perception and Health-Related Quality of Life in Individuals with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial
2021 · CoQ10 + NADH group · Adult women with ME/CFS, aged 18 years or older
200 mg8 weeks72
[L-carnitine combined with coenzyme Q10 for idiopathic oligoasthenozoospermia: A double-blind randomized controlled trial]
2018 · Combination group · Men with idiopathic oligoasthenozoospermia
60 mg90 days63
Coenzyme Q10 terclatrate and creatine in chronic heart failure: a randomized, placebo-controlled, double-blind study
2011 · Q-ter + creatine group · Patients with stable chronic heart failure secondary to left ventricular systolic dysfunction (left ventricular ejection fraction ≤35%)
320 mg8 weeks35
Protective effect of anti-oxidants on endothelial function in young Korean-Asians compared to Caucasians
2012 · antioxidant vitamins · Healthy Korean and Caucasian adults aged 20–35 years
300 mg2 weeks20
Clinical and biochemical effects of coenzyme Q(10), vitamin E, and selenium supplementation to psoriasis patients
2009 · EP1 · Patients with severe erythrodermic psoriasis
50 mg30 days—
Clinical and biochemical effects of coenzyme Q(10), vitamin E, and selenium supplementation to psoriasis patients
2009 · PsA1 · Patients with severe arthropathic psoriasis
50 mg5 weeks—
Does oral coenzyme Q10 plus NADH supplementation improve fatigue and biochemical parameters in chronic fatigue syndrome?
2015 · CoQ10 plus NADH group · Spanish patients with chronic fatigue syndrome; age and sex not reported
200 mg8 weeks—
The effect of creatine and coenzyme q10 combination therapy on mild cognitive impairment in Parkinson's disease
2015 · combination therapy · Patients with Parkinson's disease and mild cognitive impairment; age and sex not specified
300 mg548 days—
The effects of concurrent Coenzyme Q10, L-carnitine supplementation in migraine prophylaxis: A randomized, placebo-controlled, double-blind trial
2019 · Coenzyme Q10 and L-carnitine group · Men and women aged 20–40 years with migraine headache
30 mg8 weeks—
Coenzyme Q10 in patients undergoing CABG: Effect of statins and nutritional supplementation
2008 · CoQ(10) supplementation · Adults with left ventricular dysfunction undergoing CABG; age and sex not reported
150 mg4 weeks40
Women have higher levels of CoQ(10) than men when supplemented with a single dose of CoQ(10) with monoglycerides omega-3 or rice oil and followed for 48 h: a crossover randomised triple blind controlled study
2022 · CoQ10 alone · Healthy men and women aged 18–50 years
200 mg1 day30
Effects of CoQ10 supplementation on plasma lipoprotein lipid, CoQ10 and liver and muscle enzyme levels in hypercholesterolemic patients treated with atorvastatin: a randomized double-blind study
2007 · CoQ10 group · Hypercholesterolemic patients treated with atorvastatin
100 mg16 weeks24
Comparative Bioavailability of Different Coenzyme Q10 Formulations in Healthy Elderly Individuals
2020 · Standard product (SP) · Healthy adults aged 65 years or older, women and men
100 mg1 day21
Comparative Bioavailability of Different Coenzyme Q10 Formulations in Healthy Elderly Individuals
2020 · Investigational product (IP) · Healthy adults aged 65 years or older, women and men
100 mg1 day21
Coenzyme Q10 supplementation reduces oxidative stress and increases antioxidant enzyme activity in patients with coronary artery disease
2012 · Q10-150 group · Patients with coronary artery disease, including people with at least 50% stenosis of one major coronary artery or who had received percutaneous transluminal coronary angioplasty
150 mg12 weeks18
Effects of coenzyme Q10 supplementation on inflammatory markers (high-sensitivity C-reactive protein, interleukin-6, and homocysteine) in patients with coronary artery disease
2012 · Q10-150 group · Patients with coronary artery disease
150 mg12 weeks18
Coenzyme Q improves LDL resistance to ex vivo oxidation but does not enhance endothelial function in hypercholesterolemic young adults
2000 · CoQ(10) · Healthy adults with hypercholesterolemia and endothelial dysfunction at baseline; mean age 34 years (SD 10), nine women and three men
150 mg4 weeks12
Ubiquinol is superior to ubiquinone to enhance Coenzyme Q10 status in older men
2018 · ubiquinone supplement · older men; age range and health condition not reported
200 mg2 weeks10
Myocardial preservation by therapy with coenzyme Q10 during heart surgery
1993 · CoQ10 group · High-risk patients undergoing heart surgery with blood CoQ10 deficiency, low cardiac index, and low left ventricular ejection fraction
100 mg44 days10
Serum coenzyme Q10 concentrations in healthy men supplemented with 30 mg or 100 mg coenzyme Q10 for two months in a randomised controlled study
2003 · 100 mg Q10 group · healthy men
100 mg60 days—
Effect on absorption and oxidative stress of different oral Coenzyme Q10 dosages and intake strategy in healthy men
2005 · 200 mg coenzyme Q10 group · healthy men aged 18–55 years
200 mg20 days—
Effect on absorption and oxidative stress of different oral Coenzyme Q10 dosages and intake strategy in healthy men
2005 · divided-dose 2 × 100 mg coenzyme Q10 group · healthy men aged 18–55 years
200 mg20 days—
Effect on absorption and oxidative stress of different oral Coenzyme Q10 dosages and intake strategy in healthy men
2005 · 100 mg coenzyme Q10 group · healthy men aged 18–55 years
100 mg20 days—
Effect on absorption and oxidative stress of different oral Coenzyme Q10 dosages and intake strategy in healthy men
2005 · 100 mg crystalline coenzyme Q10 group · healthy men aged 18–55 years
100 mg20 days—
Relative bioavailability comparison of different coenzyme Q10 formulations with a novel delivery system
2009 · colloidal-Q10 · healthy adult men and women; age range not reported
120 mg1 day—
Relative bioavailability comparison of different coenzyme Q10 formulations with a novel delivery system
2009 · solubilizate 1 · healthy adult men and women; age range not reported
120 mg1 day—
Relative bioavailability comparison of different coenzyme Q10 formulations with a novel delivery system
2009 · oil-based formulation · healthy adult men and women; age range not reported
120 mg1 day—
Relative bioavailability comparison of different coenzyme Q10 formulations with a novel delivery system
2009 · solubilizate 2 · healthy adult men and women; age range not reported
120 mg1 day—
Effect of Coenzyme Q10 supplementation on antioxidant enzymes activity and oxidative stress of seminal plasma: a double-blind randomised clinical trial
2014 · CoQ10 group · men with idiopathic oligoasthenoteratozoospermia (OAT)
200 mg90 days—
Effects of 12 Weeks of Essential Amino Acids (EAA)-Based Multi-Ingredient Nutritional Supplementation on Muscle Mass, Muscle Strength, Muscle Power and Fatigue in Healthy Elderly Subjects: A Randomized Controlled Double-Blind Study
2019 · multi-ingredient nutritional supplement (SUPP) · Healthy men and women aged 65–80 years, not selected for a diagnosed disease; the group was described as non-sarcopenic and well-nourished
100 mg12 weeks19
Coenzyme Q10 supplementation improves cholesterol efflux capacity and antiinflammatory properties of high-density lipoprotein in Chinese adults with dyslipidemia
2022 · CoQ10 group · Adults with dyslipidemia
120 mg24 weeks51
Effect of Coenzyme Q(10) on Insulin Resistance in Korean Patients with Prediabetes: A Pilot Single-Center, Randomized, Double-Blind, Placebo-Controlled Study
2018 · experimental group · Adults aged 20–65 with impaired glucose tolerance (prediabetes)
200 mg8 weeks40
Effects of Coenzyme Q10 Supplementation on Serum Values of Gamma-glutamyl transferase, Pseudocholinesterase, Bilirubin, Ferritin, and High-Sensitivity C-Reactive Protein in Women with Type 2 Diabetes
2019 · drug group · Women with type 2 diabetes
100 mg12 weeks36
Effects of coenzyme Q10 supplementation on serum values of adiponectin, leptin, 8-isoprostane and malondialdehyde in women with type 2 diabetes
2018 · drug group · women with type 2 diabetes mellitus
100 mg12 weeks34
Reduction in asymmetric dimethylarginine plasma levels by coenzyme Q10 supplementation in patients with type 2 diabetes mellitus
2015 · CoQ10 group · Adults with type 2 diabetes mellitus
200 mg12 weeks31
The effects of coenzyme Q10 administration on glucose homeostasis parameters, lipid profiles, biomarkers of inflammation and oxidative stress in patients with metabolic syndrome
2016 · Group A · Overweight or obese adults aged 40–85 with type 2 diabetes and coronary heart disease, described as having metabolic syndrome
100 mg8 weeks30
The Effect of Coenzyme Q10 Supplementation on Pro-Inflammatory Factors and Adiponectin in Mildly Hypertensive Patients: A Randomized, Double-Blind, Placebo-Controlled Trial
2015 · coenzyme Q10 (QG) · mildly hypertensive patients; age and sex not reported
100 mg12 weeks30
The effects of coenzyme Q10 supplementation on glucose metabolism and lipid profiles in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial
2017 · CoQ10 supplements · Women diagnosed with polycystic ovary syndrome (PCOS)
100 mg12 weeks30
Clinical trial of the effects of coenzyme Q10 supplementation on glycemic control and markers of lipid profiles in diabetic hemodialysis patients
2018 · CoQ10 group · Diabetic patients receiving hemodialysis; age and sex not specified
120 mg12 weeks30
Effects of coenzyme Q10 supplementation on matrix metalloproteinases and DAS-28 in patients with rheumatoid arthritis: a randomized, double-blind, placebo-controlled clinical trial
2019 · CoQ10 · Adults aged 18–56 years with rheumatoid arthritis diagnosed at least 6 months earlier and DAS-28 > 3.2
100 mg60 days27
Serum concentration of lipoprotein(a) decreases on treatment with hydrosoluble coenzyme Q10 in patients with coronary artery disease: discovery of a new role
1999 · coenzyme Q10 group · People with acute coronary disease (acute myocardial infarction, unstable angina, or angina pectoris) and moderately raised lipoprotein(a)
120 mg4 weeks25
Effects of Coenzyme Q10 Supplementation on Inflammatory Cytokines (TNF-α, IL-6) and Oxidative Stress in Rheumatoid Arthritis Patients: A Randomized Controlled Trial
2015 · CoQ10 group · Patients with rheumatoid arthritis
100 mg60 days22
The effect of coenzyme Q10 supplementation on inflammatory and endothelial dysfunction markers in overweight/obese polycystic ovary syndrome patients
2021 · CoQ10 group · Overweight and obese women diagnosed with polycystic ovary syndrome
200 mg8 weeks22
Coenzyme Q10 administration increases antibody titer in hepatitis B vaccinated volunteers--a single blind placebo-controlled and randomized clinical study
1999 · 180 mg/day Q10 group · Volunteers vaccinated against hepatitis B; age and sex not reported
180 mg90 days21
n-3 Fatty Acid Supplementation and Leukocyte Telomere Length in Patients with Chronic Kidney Disease
2016 · CoQ · Men and women aged 25–75 years with chronic renal impairment (eGFR >15 and <60 mL/min/1.73 m²)
200 mg8 weeks21
Coenzyme Q10 consumption promotes ABCG1-mediated macrophage cholesterol efflux: a randomized, double-blind, placebo-controlled, cross-over study in healthy volunteers
2015 · CoQ10 · healthy volunteers
200 mg7 days20
The effects of coenzyme Q10 supplementation on gene expression related to insulin, lipid and inflammation in patients with polycystic ovary syndrome
2018 · CoQ10 group · Women with diagnosed polycystic ovary syndrome (PCOS)
100 mg12 weeks20
Effects of Coenzyme Q10 Supplementation on Gene Expressions Related to Insulin, Lipid, and Inflammation Pathways in Patients With Diabetic Nephropathy
2018 · Coenzyme Q10 group · Adults aged 40 to 85 with diabetic nephropathy
100 mg12 weeks20
Ubiquinone supplementation during lovastatin treatment: effect on LDL oxidation ex vivo
1998 · Ubiquinone supplementation with lovastatin · Men with coronary heart disease and hypercholesterolemia
180 mg6 weeks19
Oxidative stress and antioxidant defense in plasma after repeated bouts of supramaximal exercise: the effect of coenzyme Q10
2011 · CoQ10 · Healthy, sedentary men
100 mg8 weeks15
Antioxidative efficacy of parallel and combined supplementation with coenzyme Q10 and d-alpha-tocopherol in mildly hypercholesterolemic subjects: a randomized placebo-controlled clinical study
2000 · Q10 group · Subjects with mild hypercholesterolemia undergoing statin treatment
200 mg90 days—
Mitochondrial DNA levels in fat and blood cells from patients with lipodystrophy or peripheral neuropathy and the effect of 90 days of high-dose coenzyme Q treatment: a randomized, double-blind, placebo-controlled pilot study
2004 · Coenzyme Q group · HIV-infected patients, including people with lipodystrophy, peripheral neuropathy or neither, and healthy control subjects
200 mg90 days—
The protective role of coenzyme Q10 in renal injury associated with extracorporeal shockwave lithotripsy: a randomised, placebo-controlled clinical trial
2014 · CoQ10 group · Patients with renal lithiasis undergoing extracorporeal shockwave lithotripsy (ESWL)
200 mg2 weeks—
A randomized controlled trial of the effects of n-3 fatty acids on resolvins in chronic kidney disease
2016 · Coenzyme Q10 · Patients with chronic kidney disease; age and sex not specified.
200 mg8 weeks—
n-3 fatty acids reduce plasma 20-hydroxyeicosatetraenoic acid and blood pressure in patients with chronic kidney disease
2015 · CoQ · Patients with chronic kidney disease
200 mg8 weeks—
Functions of Coenzyme Q10 Supplementation on Liver Enzymes, Markers of Systemic Inflammation, and Adipokines in Patients Affected by Nonalcoholic Fatty Liver Disease: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial
2016 · CoQ10 group · Patients with nonalcoholic fatty liver disease (age and sex not specified)
100 mg12 weeks—
The Effect of Coenzyme Q10 Supplementation on Circulating Levels of Novel Adipokine Adipolin/CTRP12 in Overweight and Obese Patients with Type 2 Diabetes
2017 · Q10 group · Overweight and obese patients with type 2 diabetes
200 mg12 weeks—
The effect of n-3 fatty acids and coenzyme Q10 supplementation on neutrophil leukotrienes, mediators of inflammation resolution and myeloperoxidase in chronic kidney disease
2018 · CoQ · Patients with chronic kidney disease (CKD)
200 mg8 weeks—
Coenzyme Q10 improves the survival and reduces inflammatory markers in septic patients
2020 · CoQ10 group · Septic patients; age and sex not specified
200 mg7 days—
A randomized controlled trial on the coloprotective effect of coenzyme Q10 on immune-inflammatory cytokines, oxidative status, antimicrobial peptides, and microRNA-146a expression in patients with mild-to-moderate ulcerative colitis
2021 · CoQ10 group · Patients with mild-to-moderate ulcerative colitis in remission; age and sex not specified
200 mg8 weeks—
Protection by coenzyme Q10 of tissue reperfusion injury during abdominal aortic cross-clamping
1996 · group I · Patients undergoing elective vascular surgery for abdominal aortic aneurysm or obstructive aorto-iliac disease
150 mg7 days—
The effects of [omega]3 fatty acids and coenzyme Q10 on blood pressure and heart rate in chronic kidney disease: a randomized controlled trial
2009 · both supplements · Nondiabetic patients with stage 3–4 chronic kidney disease
200 mg8 weeks—
Effect of Monacolin K and COQ10 supplementation in hypertensive and hypercholesterolemic subjects with metabolic syndrome
2018 · treatment group · Adults with metabolic syndrome who had hypertension and hypercholesterolemia; mean age 57.4 years
30 mg60 days—
Increase in insulin-like growth factor 1 (IGF-1) and insulin-like growth factor binding protein 1 after supplementation with selenium and coenzyme Q10. A prospective randomized double-blind placebo-controlled trial among elderly Swedish citizens
2017 · active treatment · Elderly healthy Swedish adults, mean age about 76 years; both sexes; some had hypertension, ischemic heart disease, or diabetes
200 mg1461 days117
Coenzyme Q10 therapy before cardiac surgery improves mitochondrial function and in vitro contractility of myocardial tissue
2005 · coenzyme Q(10) · Patients undergoing elective cardiac surgery
300 mg2 weeks62
Coenzyme Q10 supplementation in acute ischemic stroke: Is it beneficial in short-term administration?
2020 · CoQ10-supplemented group · Patients with acute ischemic stroke; age and sex not specified
300 mg4 weeks30
Women have higher levels of CoQ(10) than men when supplemented with a single dose of CoQ(10) with monoglycerides omega-3 or rice oil and followed for 48 h: a crossover randomised triple blind controlled study
2022 · CoQ10 + rice oil · Healthy men and women aged 18–50 years
200 mg1 day30
Comparative bioavailability of two novel coenzyme Q10 preparations in humans
2003 · fast-melting tablet · adult male subjects; age and health status not reported
60 mg1 day24
Comparative bioavailability of two novel coenzyme Q10 preparations in humans
2003 · effervescent tablet · adult male subjects; age and health status not reported
60 mg1 day24
Comparative bioavailability of two novel coenzyme Q10 preparations in humans
2003 · soft gelatin preparation · adult male subjects; age and health status not reported
60 mg1 day24
Comparative bioavailability of two novel coenzyme Q10 preparations in humans
2003 · powder-filled hard-shell preparation · adult male subjects; age and health status not reported
60 mg1 day24
Coenzyme Q10 supplementation reduces oxidative stress and increases antioxidant enzyme activity in patients with coronary artery disease
2012 · Q10-60 group · Patients with coronary artery disease, including people with at least 50% stenosis of one major coronary artery or who had received percutaneous transluminal coronary angioplasty
60 mg12 weeks19
Effects of coenzyme Q10 supplementation on inflammatory markers (high-sensitivity C-reactive protein, interleukin-6, and homocysteine) in patients with coronary artery disease
2012 · Q10-60 group · Patients with coronary artery disease
60 mg12 weeks19
Relative bioavailability and antioxidant potential of two coenzyme q10 preparations
2003 · BT-CoQ10 · 11 healthy individuals
300 mg7 days11
Relative bioavailability and antioxidant potential of two coenzyme q10 preparations
2003 · Commercial grade CoQ10 · 11 healthy individuals
300 mg7 days11
Total coenzyme Q10 concentrations in Asian men following multiple oral 50-mg doses administered as coenzyme Q10 sustained release tablets or regular tablets
2003 · Group I · Healthy men aged 19–23 years
50 mg15 days10
Total coenzyme Q10 concentrations in Asian men following multiple oral 50-mg doses administered as coenzyme Q10 sustained release tablets or regular tablets
2003 · Group II · Healthy men aged 19–23 years
50 mg15 days10
Relative bioavailability of coenzyme Q10 formulation for paediatric individualized therapy
2017 · commercial-grade CoQ10 powder (solid formulation) · Six healthy individuals; ages and sex not specified
250 mg7 days6
Relative bioavailability of coenzyme Q10 formulation for paediatric individualized therapy
2017 · oil-in-water liquid emulsion · Six healthy individuals; ages and sex not specified
250 mg7 days6
Comparison of the relative bioavailability of different coenzyme Q10 formulations with a novel solubilizate (Solu Q10)
2006 · Solu Q10 solubilizate formulation · Healthy volunteers; age and sex not specified
60 mg2 weeks—
Comparison of the relative bioavailability of different coenzyme Q10 formulations with a novel solubilizate (Solu Q10)
2006 · Other solubilizate formulations · Healthy volunteers; age and sex not specified
60 mg2 weeks—
Comparison of the relative bioavailability of different coenzyme Q10 formulations with a novel solubilizate (Solu Q10)
2006 · Oily dispersion formulations · Healthy volunteers; age and sex not specified
60 mg2 weeks—
Comparison of the relative bioavailability of different coenzyme Q10 formulations with a novel solubilizate (Solu Q10)
2006 · Crystalline CoQ10 formulation · Healthy volunteers; age and sex not specified
60 mg2 weeks—
Selenoprotein P increases upon selenium and coenzyme Q(10) supplementation and is associated with telomere length, quality of life and reduced inflammation and mortality
2024 · selenium yeast and coenzyme Q 10 supplementation · elderly community-living participants with low selenium status
200 mg4 years—
Effects of a new combination of nutraceuticals with Morus alba on lipid profile, insulin sensitivity and endotelial function in dyslipidemic subjects. A cross-over, randomized, double-blind trial
2015 · Combination A · Adults aged 18–70 with hypercholesterolemia not requiring statins or statin-intolerant
2 mg4 weeks23
Nutraceutical approach for the management of cardiovascular risk - a combination containing the probiotic Bifidobacterium longum BB536 and red yeast rice extract: results from a randomized, double-blind, placebo-controlled study
2019 · Nutraceutical combination · Adults aged 18–70 with low cardiovascular risk, in primary cardiovascular prevention, and LDL-C of 130–200 mg/dL
20 mg12 weeks16
Effect of a food supplement containing berberine, monacolin K, hydroxytyrosol and coenzyme Q(10) on lipid levels: a randomized, double-blind, placebo controlled study
2017 · Body Lipid (BL) · Adults aged 18–75, both sexes, with mild-to-moderate hypercholesterolemia
2 mg4 weeks—
Effect of a food supplement containing berberine, monacolin K, hydroxytyrosol and coenzyme Q(10) on lipid levels: a randomized, double-blind, placebo controlled study
2017 · Armolipid Plus (AM) · Adults aged 18–75, both sexes, with mild-to-moderate hypercholesterolemia
2 mg4 weeks—
Levels of sP-selectin and hs-CRP Decrease with Dietary Intervention with Selenium and Coenzyme Q10 Combined: A Secondary Analysis of a Randomized Clinical Trial
2015 · Active treatment · Adults aged 70–88 years from an elderly Swedish community population; no condition required for inclusion
200 mg1461 days221
Significant Changes in Metabolic Profiles after Intervention with Selenium and Coenzyme Q10 in an Elderly Population
2019 · SeQ10 active treatment group · Men aged 70–88 from a healthy elderly community-living population
200 mg4 years221
Effects of an Intervention with Selenium and Coenzyme Q(10) on Five Selected Age-Related Biomarkers in Elderly Swedes Low in Selenium: Results That Point to an Anti-Ageing Effect-A Sub-Analysis of a Previous Prospective Double-Blind Placebo-Controlled Randomised Clinical Trial
2023 · Active treatment · Elderly community-dwelling Swedes with low selenium status; age range not stated at intervention
200 mg1461 days220
Effects of EPA, γ-linolenic acid or coenzyme Q10 on serum prostate-specific antigen levels: a randomised, double-blind trial
2013 · group 3 (CoQ10) · Healthy men with serum PSA ≤ 2.5 ng/ml
400 mg12 weeks126
Decreased Concentration of Fibroblast Growth Factor 23 (FGF-23) as a Result of Supplementation with Selenium and Coenzyme Q(10) in an Elderly Swedish Population: A Sub-Analysis
2022 · active treatment group · Swedish adults aged 70–88 with low selenium status
200 mg1461 days118
Selenium and Coenzyme Q10 Supplementation Improves Renal Function in Elderly Deficient in Selenium: Observational Results and Results from a Subgroup Analysis of a Prospective Randomised Double-Blind Placebo-Controlled Trial
2020 · Active supplementation with selenium and coenzyme Q10 · Adults aged 70–88 years with low pre-intervention selenium status, living in the community
200 mg1461 days117
Efficacy of coenzyme Q10 on semen parameters, sperm function and reproductive hormones in infertile men
2009 · group 1 · Infertile men with idiopathic oligoasthenoteratospermia
300 mg26 weeks106
Dietary Supplementation with Selenium and Coenzyme Q(10) Prevents Increase in Plasma D-Dimer While Lowering Cardiovascular Mortality in an Elderly Swedish Population
2021 · Active treatment · Adults aged 70–88 years living in a Swedish rural community, with suboptimal serum selenium status; the analysed group excluded people with atrial fibrillation or anticoagulant treatment, malignancy, or left atrium dimension over 40 mm.
200 mg4 years106
Selenium and Coenzyme Q(10) Intervention Prevents Telomere Attrition, with Association to Reduced Cardiovascular Mortality-Sub-Study of a Randomized Clinical Trial
2022 · active treatment · Adults aged over 69 years living in a rural municipality in Sweden, with low selenium status; elderly population
200 mg4 years67
NT-Pro BNP Predicts Myocardial Injury Post-vascular Surgery and is Reduced with CoQ(10): A Randomized Double-Blind Trial
2020 · CoQ 10 · Patients undergoing elective vascular surgery, including patients with cardiovascular risk factors
400 mg3 days62
Reversal of mitochondrial dysfunction by coenzyme Q10 supplement improves endothelial function in patients with ischaemic left ventricular systolic dysfunction: a randomized controlled trial
2011 · CoQ supplement · Patients with ischaemic left ventricular systolic dysfunction
300 mg8 weeks28
Significant changes in circulating microRNA by dietary supplementation of selenium and coenzyme Q10 in healthy elderly males. A subgroup analysis of a prospective randomized double-blind placebo-controlled trial among elderly Swedish citizens
2017 · Active treatment · Men aged 70–80 years in a community-based elderly population; some had hypertension or ischemic heart disease, and many had low selenium status
200 mg4 years25
Effects of coenzyme Q10 supplementation (300 mg/day) on antioxidation and anti-inflammation in coronary artery disease patients during statins therapy: a randomized, placebo-controlled trial
2013 · coenzyme Q10 (Q10-300 group) · Adults with coronary artery disease receiving statin therapy; women were postmenopausal and not receiving hormone therapy.
300 mg12 weeks23
Effects of curcumin and/or coenzyme Q10 supplementation on metabolic control in subjects with metabolic syndrome: a randomized clinical trial
2022 · QP group (coenzyme Q10 plus placebo) · Adults aged 18 years or older with metabolic syndrome; men and women
60 mg12 weeks22
Coenzyme Q10 administration increases antibody titer in hepatitis B vaccinated volunteers--a single blind placebo-controlled and randomized clinical study
1999 · 90 mg/day Q10 group · Volunteers vaccinated against hepatitis B; age and sex not reported
90 mg90 days21
Coenzyme Q10 improves contractility of dysfunctional myocardium in chronic heart failure
2005 · CoQ(10) · Adults with stable NYHA class II or III chronic heart failure secondary to ischemic heart disease; mean age 59 years
300 mg4 weeks21
Effects of coenzyme Q10 supplementation on antioxidant capacity and inflammation in hepatocellular carcinoma patients after surgery: a randomized, placebo-controlled trial
2016 · Q10-300 group · Adults aged 20–80 with primary hepatocellular carcinoma after tumor resection
300 mg12 weeks21
The antioxidant effect of ubiquinone and combined therapy on mitochondrial function in blood cells in non-proliferative diabetic retinopathy: A randomized, double-blind, phase IIa, placebo-controlled study
2016 · Ubiquinone · Adults aged 30–75 with type 2 diabetes and non-proliferative diabetic retinopathy
400 mg26 weeks20
The effect of ubiquinone and combined antioxidant therapy on oxidative stress markers in non-proliferative diabetic retinopathy: A phase IIa, randomized, double-blind, and placebo-controlled study
2016 · Coenzyme Q10 · Adults with type 2 diabetes and non-proliferative diabetic retinopathy, without macular edema; males and females
400 mg26 weeks20
Coenzyme Q10 dose-escalation study in hemodialysis patients: safety, tolerability, and effect on oxidative stress
2015 · 300 mg/day dose period · Adults aged 18–85 with end-stage renal disease receiving maintenance hemodialysis and elevated baseline F2-isoprostanes
300 mg2 weeks20
Effect of coenzyme Q10 supplementation on oxidative stress and clinical outcomes in patients with low levels of coenzyme Q10 admitted to the intensive care unit
2021 · Intervention group · Adults aged 18–65 with traumatic injury, sub-therapeutic plasma CoQ10, and expected need for mechanical ventilation and ICU stay
400 mg7 days20
Effect of coenzyme Q10 administration on endothelial function and extracellular superoxide dismutase in patients with ischaemic heart disease: a double-blind, randomized controlled study
2007 · CoQ(10)-treated group · Adults with coronary artery disease; mean age 55 years; 33 men and 5 women enrolled across the study
300 mg30 days19
Reducing exercise-induced muscular injury in kendo athletes with supplementation of coenzyme Q10
2008 · CoQ10 group · Male elite Japanese kendo athletes; age not reported
300 mg20 days10
Effect of Short-term Coenzyme Q10 Supplementation and Precooling on Serum Endogenous Antioxidant Enzymes of Elite Swimmers
2018 · CoQ10 · Healthy male elite adolescent swimmers, mean age 17.5 years
300 mg2 weeks9
Effect of Short-term Coenzyme Q10 Supplementation and Precooling on Serum Endogenous Antioxidant Enzymes of Elite Swimmers
2018 · Supplementation with precooling · Healthy male elite adolescent swimmers, mean age 17.5 years
300 mg2 weeks9
Cellular redox activity of coenzyme Q10: effect of CoQ10 supplementation on human skeletal muscle
2002 · CoQ10-treated subjects · Aged individuals receiving CoQ10 before hip replacement surgery; sex and age range not reported
300 mg4 weeks—
Selenium and coenzyme Q(10) improve the systemic redox status while reducing cardiovascular mortality in elderly population-based individuals
2023 · selenium and coenzyme Q10 supplementation · Elderly community-dwelling individuals with low levels of selenium and coenzyme Q10
200 mg4 years—
Complementary therapy in diabetic patients with chronic complications: a pilot study
2010 · QALAPL group · Patients with diabetes; age and sex not reported
60 mg90 days20
Serum coenzyme Q10 concentrations in healthy men supplemented with 30 mg or 100 mg coenzyme Q10 for two months in a randomised controlled study
2003 · 30 mg Q10 group · healthy men
30 mg60 days—
Coenzyme Q10 absorption and tolerance in children with Down syndrome: a dose-ranging trial
2006 · High-dose, one daily dose · Children with Down syndrome; age range and sex not reported
10 mg/kg60 days—
Coenzyme Q10 absorption and tolerance in children with Down syndrome: a dose-ranging trial
2006 · High-dose, split into two daily doses · Children with Down syndrome; age range and sex not reported
10 mg/kg60 days—
Safety assessment of PureSorb-Q40 in healthy subjects and serum coenzyme Q10 level in excessive dosing
2007 · P40 group · Healthy volunteers
900 mg4 weeks—
Bioavailability and Cellular Compatibility of a Novel Coenzyme Q(10) Emulgel as an Alternative Oral Delivery System for Patients with Dysphagia: Preliminary Results from a Randomized Study
2026 · Emulgel, single-dose study · Healthy adults; age and sex not reported
1 g1 day—
Bioavailability and Cellular Compatibility of a Novel Coenzyme Q(10) Emulgel as an Alternative Oral Delivery System for Patients with Dysphagia: Preliminary Results from a Randomized Study
2026 · Solid capsules, single-dose study · Healthy adults; age and sex not reported
1 g1 day—
Coenzyme Q10 mitigates macrophage mediated inflammation in heart following myocardial infarction via the NLRP3/IL1β pathway
2024 · CoQ10 group · adults with myocardial infarction successfully treated with percutaneous coronary intervention
30 mg90 days61
Dietary intake of coenzyme Q10 reduces oxidative stress in patients with acute ischemic stroke: a double-blind, randomized placebo-controlled study
2025 · CoQ10 group · Patients hospitalized for acute ischemic stroke; age and sex not specified
600 mg30 days25
Coenzyme Q10 supplementation reduces oxidative stress and increases antioxidant enzyme activity in patients with relapsing-remitting multiple sclerosis
2013 · CoQ10 supplement · Patients with relapsing-remitting multiple sclerosis; age and sex not specified
500 mg12 weeks24
Coenzyme Q10 supplementation ameliorates inflammatory markers in patients with multiple sclerosis: a double blind, placebo, controlled randomized clinical trial
2015 · Coenzyme Q10-supplemented group · Patients with relapsing-remitting multiple sclerosis; age and sex not stated
500 mg12 weeks24
Effects of curcumin and/or coenzyme Q10 supplementation on metabolic control in subjects with metabolic syndrome: a randomized clinical trial
2022 · CQ group (curcumin plus coenzyme Q10) · Adults aged 18 years or older with metabolic syndrome; men and women
60 mg12 weeks22
Complementary therapy in diabetic patients with chronic complications: a pilot study
2010 · QALA group · Patients with diabetes; age and sex not reported
60 mg90 days20
Coenzyme Q10 dose-escalation study in hemodialysis patients: safety, tolerability, and effect on oxidative stress
2015 · 600 mg/day dose period · Adults aged 18–85 with end-stage renal disease receiving maintenance hemodialysis and elevated baseline F2-isoprostanes
600 mg2 weeks19
Coenzyme Q10 dose-escalation study in hemodialysis patients: safety, tolerability, and effect on oxidative stress
2015 · 1200 mg/day dose period · Adults aged 18–85 with end-stage renal disease receiving maintenance hemodialysis and elevated baseline F2-isoprostanes
1.2 g2 weeks18
Coenzyme Q10 dose-escalation study in hemodialysis patients: safety, tolerability, and effect on oxidative stress
2015 · 1800 mg/day dose period · Adults aged 18–85 with end-stage renal disease receiving maintenance hemodialysis and elevated baseline F2-isoprostanes
1.8 g2 weeks15
MitoQ supplementation does not impact redox responses to acute exercise in skeletal muscle of older individuals
2025 · MitoQ group · Healthy older men and women, approximately 70 years old, without chronic illness
20 mg12 weeks11
Increased serum and low-density-lipoprotein antioxidant potential after antioxidant supplementation in endurance athletes
1997 · antioxidant trial · Eight endurance athletes
60 mg4 weeks8
Antioxidants for Alzheimer disease: a randomized clinical trial with cerebrospinal fluid biomarker measures
2012 · CoQ · Adults aged 50–85 with probable Alzheimer disease and MMSE scores of 16 or more
1.2 g16 weeks—
Effect of Coenzyme Q(10) on Biomarkers of Oxidative Stress and Cardiac Function in Hemodialysis Patients: The CoQ(10) Biomarker Trial
2017 · 600 mg CoQ10 group · Adults aged over 18 and under 85 receiving maintenance hemodialysis
600 mg120 days—
Effect of Coenzyme Q(10) on Biomarkers of Oxidative Stress and Cardiac Function in Hemodialysis Patients: The CoQ(10) Biomarker Trial
2017 · 1200 mg CoQ10 group · Adults aged over 18 and under 85 receiving maintenance hemodialysis
1.2 g120 days—
Coenzyme Q(10) supplementation reduces oxidative stress and decreases antioxidant enzyme activity in children with autism spectrum disorders
2018 · 30 mg daily group · Children with autism spectrum disorders diagnosed using DSM-IV criteria and assessed with CARS
30 mg100 days—
Women have higher levels of CoQ(10) than men when supplemented with a single dose of CoQ(10) with monoglycerides omega-3 or rice oil and followed for 48 h: a crossover randomised triple blind controlled study
2022 · CoQ10 + MAG-OM3 · Healthy men and women aged 18–50 years
200 mg1 day30
Effect of combined coenzyme Q10 and d-alpha-tocopheryl acetate supplementation on exercise-induced lipid peroxidation and muscular damage: a placebo-controlled double-blind study in marathon runners
1998 · antioxidant cocktail · Moderately trained male marathon runners
90 mg3 weeks18
Antioxidative efficacy of parallel and combined supplementation with coenzyme Q10 and d-alpha-tocopherol in mildly hypercholesterolemic subjects: a randomized placebo-controlled clinical study
2000 · Q10 and d-alpha-tocopherol group · Subjects with mild hypercholesterolemia undergoing statin treatment
200 mg90 days—
Six-month supplementation with high dose coenzyme Q10 improves liver steatosis, endothelial, vascular and myocardial function in patients with metabolic-dysfunction associated steatotic liver disease: a randomized double-blind, placebo-controlled trial
2024 · CoQ10 group · Adults aged 18 years or older with metabolic-dysfunction associated steatotic liver disease and at least one extra cardiometabolic risk factor, without diabetes mellitus
240 mg26 weeks30
Comparison of L-Carnitine vs. Coq10 and Vitamin E for idiopathic male infertility: a randomized controlled trial
2022 · control group · men with asthenozoospermia and teratozoospermia
30 mg90 days70
Circulating levels of reactive oxygen species in patients with nonproliferative diabetic retinopathy and the influence of antioxidant supplementation: 6-month follow-up
2015 · Group A (antioxidant dietary supplementation) · Adults aged 40–79 with type 2 diabetes and mild or moderate nonproliferative diabetic retinopathy
20 mg26 weeks34
Coenzyme Q10 and antioxidants in acute myocardial infarction
1994 · verum group · Patients admitted with acute myocardial infarction and symptom duration under 6 hours
100 mg1 year32
n-3 Fatty Acid Supplementation and Leukocyte Telomere Length in Patients with Chronic Kidney Disease
2016 · n-3 fatty acids + CoQ · Men and women aged 25–75 years with chronic renal impairment (eGFR >15 and <60 mL/min/1.73 m²)
200 mg8 weeks18
Effect of coenzyme Q10, riboflavin and niacin on serum CEA and CA 15-3 levels in breast cancer patients undergoing tamoxifen therapy
2007 · Group IV (CoRN for 45 days) · Breast cancer patients undergoing tamoxifen therapy; age and sex not specified
100 mg45 days—
Effect of coenzyme Q10, riboflavin and niacin on serum CEA and CA 15-3 levels in breast cancer patients undergoing tamoxifen therapy
2007 · Group V (CoRN for 90 days) · Breast cancer patients undergoing tamoxifen therapy; age and sex not specified
100 mg90 days—
Serum cytokine levels of interleukin-1beta, -6, -8, tumour necrosis factor-alpha and vascular endothelial growth factor in breast cancer patients treated with tamoxifen and supplemented with co-enzyme Q(10), riboflavin and niacin
2007 · Group IV (CoRN for 45 days) · Breast cancer patients treated with tamoxifen
100 mg45 days—
Serum cytokine levels of interleukin-1beta, -6, -8, tumour necrosis factor-alpha and vascular endothelial growth factor in breast cancer patients treated with tamoxifen and supplemented with co-enzyme Q(10), riboflavin and niacin
2007 · Group V (CoRN for 90 days) · Breast cancer patients treated with tamoxifen
100 mg90 days—
Co-enzyme Q10, riboflavin and niacin supplementation on alteration of DNA repair enzyme and DNA methylation in breast cancer patients undergoing tamoxifen therapy
2008 · CoRN supplement plus tamoxifen · Breast cancer patients undergoing tamoxifen therapy
100 mg——
Anti-angiogenic potential of CoenzymeQ10, riboflavin and niacin in breast cancer patients undergoing tamoxifen therapy
2008 · Group IV (CoRN for 45 days) · Breast cancer patients receiving tamoxifen therapy for more than 1 year; age not reported
100 mg45 days—
Anti-angiogenic potential of CoenzymeQ10, riboflavin and niacin in breast cancer patients undergoing tamoxifen therapy
2008 · Group V (CoRN for 90 days) · Breast cancer patients receiving tamoxifen therapy for more than 1 year; age not reported
100 mg90 days—
n-3 fatty acids reduce plasma 20-hydroxyeicosatetraenoic acid and blood pressure in patients with chronic kidney disease
2015 · n-3 fatty acids and CoQ · Patients with chronic kidney disease
200 mg8 weeks—
Addition of omega-3 fatty acid and coenzyme Q10 to statin therapy in patients with combined dyslipidemia
2017 · third group (statin + omega-3 PUFA + CoQ10) · People with combined dyslipidemia and elevated TAG levels; age and sex not reported
200 mg90 days—
The effect of n-3 fatty acids and coenzyme Q10 supplementation on neutrophil leukotrienes, mediators of inflammation resolution and myeloperoxidase in chronic kidney disease
2018 · n-3 FA plus CoQ · Patients with chronic kidney disease (CKD)
200 mg8 weeks—
Effects of poly-bioactive compounds on lipid profile and body weight in a moderately hypercholesterolemic population with low cardiovascular disease risk: a multicenter randomized trial
2014 · Intervention (Armolipid Plus/AP) · Men and women older than 18 years with mild-moderate hypercholesterolemia and elevated LDL-c, candidates for lifestyle intervention without hypolipemic drug treatment
2 mg12 weeks51
Effects of a Combined Nutraceutical on Lipid Pattern, Glucose Metabolism and Inflammatory Parameters in Moderately Hypercholesterolemic Subjects: A Double-blind, Cross-over, Randomized Clinical Trial
2017 · Active nutraceutical · Adults aged 25–75 with moderately elevated cholesterol and metabolic syndrome, in primary cardiovascular prevention
50 mg6 weeks30
The impact of a standardized micronutrient supplementation on PCOS-typical parameters: a randomized controlled trial
2019 · Multinutrient supplementation group · Women aged 19–35 with polycystic ovary syndrome (PCOS)
30 mg90 days30
Dietary intervention with a specific micronutrient combination for the treatment of patients with cardiac arrhythmias: the impact on insulin resistance and left ventricular function
2018 · verum group · Adults aged 18–75 with cardiac arrhythmias (ventricular or supraventricular premature beats or supraventricular tachycardia); patients with cardiovascular disorders, often including hypertension or coronary artery disease
60 mg6 weeks29
Effects of a New Combination of Medical Food on Endothelial Function and Lipid Profile in Dyslipidemic Subjects: A Pilot Randomized Trial
2019 · Nutraceutical B · Adults aged 18–75 with elevated serum cholesterol not requiring statins or statin-intolerant; people with cardiovascular disease and uncontrolled diabetes were excluded.
2 mg6 weeks23
Effects of a Combination of Water-Soluble CoenzymeQ10 and Collagen on Skin Parameters and Condition:Results of a Randomised, Placebo-Controlled,Double-Blind Study
2020 · test group · Healthy Caucasian women aged 40–65 with signs of skin aging
50 mg12 weeks17
Peroxidation of LDL from combined-hyperlipidemic male smokers supplied with omega-3 fatty acids and antioxidants
1997 · antioxidants · male smokers with combined hyperlipidemia
30 mg6 weeks—
Peroxidation of LDL from combined-hyperlipidemic male smokers supplied with omega-3 fatty acids and antioxidants
1997 · omega-3 FAs and antioxidants · male smokers with combined hyperlipidemia
30 mg6 weeks—
A randomized controlled trial of the effects of n-3 fatty acids on resolvins in chronic kidney disease
2016 · n-3 fatty acids and Coenzyme Q10 · Patients with chronic kidney disease; age and sex not specified.
200 mg8 weeks—